John S. Mcbride serves as Executive at Tokai Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, John S. Mcbride has executed 10 insider transactions totaling $315.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 10, 2026 involved exercising options for 3,430 shares valued at $0.
John S. Mcbride currently holds 3,430 shares of Tokai Pharmaceuticals Inc (TKAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John S. Mcbride has been a net seller of TKAI stock. They have purchased $0 and sold $315.2K worth of shares.
John S. Mcbride's most recent insider trade was on Jan 10, 2026, when they sold 3,430 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 21, 2015 | TKAI | $56.6K | Option Exercise | 13,500 | $4.19 | Discretionary |
| Sep 21, 2015 | TKAI | $189.1K | Sale | 13,500 | $14.01 | Discretionary |
| Jun 24, 2015 | TKAI | $4.3K | Sale | 300 | $14.20 | Discretionary |
| Jun 24, 2015 | TKAI | $1.3K | Option Exercise | 300 | $4.19 | Discretionary |
| Jun 23, 2015 | TKAI | $93.8K | Sale | 6,700 | $14.00 | Discretionary |
| Jun 23, 2015 | TKAI | $28.1K | Option Exercise | 6,700 | $4.19 | Discretionary |
| Jun 22, 2015 | TKAI | $8.4K | Option Exercise | 2,000 | $4.19 | Discretionary |
| Jun 22, 2015 | TKAI | $28.0K | Sale | 2,000 | $14.02 | Discretionary |